160 related articles for article (PubMed ID: 27671295)
1. Design and Synthesis of NO-releasing Betulinic Acid Derivatives as Potential Anticancer Agents.
Liu J; Zhu Z; Tang J; Lin Q; Chen L; Sun J
Anticancer Agents Med Chem; 2017; 17(2):241-249. PubMed ID: 27671295
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and anti-tumor activity of novel betulinic acid derivatives.
Liu JH; Tang J; Zhu ZF; Chen L
J Asian Nat Prod Res; 2014 Jan; 16(1):34-42. PubMed ID: 24350921
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
Shi W; Tang N; Yan WD
J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
[TBL] [Abstract][Full Text] [Related]
4. Novel semisynthetic derivatives of betulin and betulinic acid with cytotoxic activity.
Santos RC; Salvador JA; Marín S; Cascante M
Bioorg Med Chem; 2009 Sep; 17(17):6241-50. PubMed ID: 19674909
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3-hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents.
Mukherjee R; Jaggi M; Rajendran P; Srivastava SK; Siddiqui MJ; Vardhan A; Burman AC
Bioorg Med Chem Lett; 2004 Jun; 14(12):3169-72. PubMed ID: 15149668
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship study of novel cytotoxic carbamate and N-acylheterocyclic bearing derivatives of betulin and betulinic acid.
Santos RC; Salvador JA; Marín S; Cascante M; Moreira JN; Dinis TC
Bioorg Med Chem; 2010 Jun; 18(12):4385-96. PubMed ID: 20494586
[TBL] [Abstract][Full Text] [Related]
9. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
10. A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification.
Ding W; Sun M; Luo S; Xu T; Cao Y; Yan X; Wang Y
Molecules; 2013 Aug; 18(9):10228-41. PubMed ID: 23973995
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of 3-O-acylated betulinic acid derivatives obtained by enzymatic synthesis.
Ahmad FB; Ghaffari Moghaddam M; Basri M; Abdul Rahman MB
Biosci Biotechnol Biochem; 2010; 74(5):1025-9. PubMed ID: 20460723
[TBL] [Abstract][Full Text] [Related]
13. Betulinic acid and its derivatives as anti-angiogenic agents.
Mukherjee R; Jaggi M; Rajendran P; Siddiqui MJ; Srivastava SK; Vardhan A; Burman AC
Bioorg Med Chem Lett; 2004 May; 14(9):2181-4. PubMed ID: 15081004
[TBL] [Abstract][Full Text] [Related]
14. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anticancer activity of novel betulinic acid and betulin derivatives.
Kommera H; Kaluderović GN; Kalbitz J; Paschke R
Arch Pharm (Weinheim); 2010 Aug; 343(8):449-57. PubMed ID: 20726008
[TBL] [Abstract][Full Text] [Related]
16. A convergent synthesis of novel alkyne-azide cycloaddition congeners of betulinic acid as potent cytotoxic agent.
Dangroo NA; Singh J; Rath SK; Gupta N; Qayum A; Singh S; Sangwan PL
Steroids; 2017 Jul; 123():1-12. PubMed ID: 28435038
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-Targeted Lupane Triterpenoid Derivatives and Their Selective Apoptosis-Inducing Anticancer Mechanisms.
Ye Y; Zhang T; Yuan H; Li D; Lou H; Fan P
J Med Chem; 2017 Jul; 60(14):6353-6363. PubMed ID: 28671831
[TBL] [Abstract][Full Text] [Related]
19. New ursolic and betulinic derivatives as potential cytotoxic agents.
Baglin I; Poumaroux A; Nour M; Tan K; Mitaine-Offer AC; Lacaille-Dubois MA; Chauffert B; Cavé C
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):111-7. PubMed ID: 12943194
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Biological Evaluation of Betulinic Acid Derivatives as New Antitumor Agents for Leukemia.
Waechter F; da Silva GNS; Willig JB; de Oliveira CB; Vieira BD; Trivella DBB; Zimmer AR; Buffon A; Pilger DA; Gnoatto SCB
Anticancer Agents Med Chem; 2017; 17(13):1777-1785. PubMed ID: 28403779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
